The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis. (24th December 2012)

• Record Type: Journal Article
• Authors: Lebrun, Jean-Jacques
• Other Names: Christophe D. Academic Editor.; Richter S. N. Academic Editor.
• Is Part Of: ISRN molecular biology. Volume 2012(2012)
• Publication Date: 2012-12-24
• Subjects: Molecular biology -- Periodicals; Biochemical Phenomena; Molecular biology; Periodical; Periodicals; Electronic journals; 572.8
• DOI: 10.5402/2012/381428
• Languages: English
• ISSNs: 2090-7907

Abstract

Abstract : The transforming growth factor-beta (TGF β ) superfamily encompasses widespread and evolutionarily conserved polypeptide growth factors that regulate and orchestrate growth and differentiation in all cell types and tissues. While they regulate asymmetric cell division and cell fate determination during early development and embryogenesis, TGF β family members play a major regulatory role in hormonal and immune responses, cell growth, cell death and cell immortalization, bone formation, tissue remodeling and repair, and erythropoiesis throughout adult life. The biological and physiological functions of TGF β, the founding member of this family, and its receptors are of central importance to human diseases, particularly cancer. By regulating cell growth, death, and immortalization, TGF β signaling pathways exert tumor suppressor effects in normal cells and early carcinomas. Thus, it is not surprising that a high number of human tumors arise due to mutations or deletions in the genes coding for the various TGF β signaling components. As tumors develop and progress, these protective and cytostatic effects of TGF β are often lost. TGF β signaling then switches to promote cancer progression, invasion, and tumor metastasis. The molecular mechanisms underlying this dual role of TGF β in human cancer will be discussed in depth in this paper, and it will highlight the challenge and importance of developing novel therapeutic strategies specifically aimed at blocking the prometastatic arm of the TGF β signaling pathway without affecting its tumor suppressive effects.